Epigenetic reprogramming in liver fibrosis and cancer

被引：68
|
作者：
Wilson, Caroline L. [1 ]
Mann, Derek A. [1 ]
Borthwick, Lee A. [1 ]
机构：
[1] Newcastle Univ, Inst Cellular Med, Fibrosis Res Grp, Newcastle Upon Tyne, Tyne & Wear, England
来源：
ADVANCED DRUG DELIVERY REVIEWS | 2017年 / 121卷
基金：
英国医学研究理事会;
关键词：
Hepatic Stellate Cell; Hepatocellular carcinoma; DNA methylation; Histone modifications; Non-coding RNAs; HEPATIC STELLATE CELLS; HISTONE DEACETYLASE INHIBITOR; NONALCOHOLIC FATTY LIVER; DNA METHYLATION; HEPATOCELLULAR-CARCINOMA; MYOFIBROBLAST TRANSDIFFERENTIATION; CIRCADIAN-RHYTHM; DOWN-REGULATION; MAMMALIAN DNA; UP-REGULATION;
D O I：
10.1016/j.addr.2017.10.011
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Novel insights into the epigenetic control of chronic liver diseases are now emerging. Recent advances in our understanding of the critical roles of DNA methylation, histone modifications and ncRNA may now be exploited to improve management of fibrosis/cirrhosis and cancer. Furthermore, improved technologies for the detection of epigenetic markers from patients' blood and tissues will vastly improve diagnosis, treatment options and prognostic tracking. The aim of this review is to present recent findings from the field of liver epigenetics and to explore their potential for translation into therapeutics to prevent disease promoting epigenome reprogramming and reverse epigenetic changes. (C) 2017 The Authors. Published by Elsevier B.V.
引用
收藏
页码：124 / 132
页数：9
相关论文
共 50 条
  • [21] Epigenetic memory in the context of nuclear reprogramming and cancer
    Halley-Stott, Richard P.
    Gurdon, John B.
    [J]. BRIEFINGS IN FUNCTIONAL GENOMICS, 2013, 12 (03) : 164 - 173
  • [22] Stemness and Reprogramming in Liver Cancer
    Thorgeirsson, Snorri S.
    [J]. HEPATOLOGY, 2016, 63 (04) : 1068 - 1070
  • [23] In vivo reprogramming of myofibroblasts into hepatocytes as a therapy for liver fibrosis
    Rezvani, Milad
    Espanol-Suner, Regina
    Malato, Yann
    Dumont, Laure
    Grimm, Andrew A.
    Kienle, Eike
    Bindmann, Julia
    Wiedtke, Ellen
    Naqvi, Syed J.
    Derderian, S. C.
    Schwabe, Robert F.
    Grimm, Dirk
    Willenbring, Holger
    [J]. HEPATOLOGY, 2015, 62 : 259A - 259A
  • [24] Identifying New Epigenetic Drivers of Liver Fibrosis
    Argemi, Josepmaria
    Bataller, Ramon
    [J]. CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2019, 7 (01): : 237 - 238
  • [25] Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives
    Wang, Yingjie
    Liu, Hongyu
    Zhang, Mengsha
    Xu, Jing
    Zheng, Liuxian
    Liu, Pengpeng
    Chen, Jingyao
    Chen, Chong
    [J]. MEDCOMM, 2024, 5 (09):
  • [26] Epigenetic reprogramming of breast cancer cells with oocyte extracts
    Allegrucci, Cinzia
    Rushton, Michael D.
    Dixon, James E.
    Sottile, Virginie
    Shah, Mansi
    Kumari, Rajendra
    Watson, Sue
    Alberio, Ramiro
    Johnson, Andrew D.
    [J]. MOLECULAR CANCER, 2011, 10
  • [27] Cellular reprogramming to model and study epigenetic alterations in cancer
    Kim, Jungsun
    [J]. STEM CELL RESEARCH, 2020, 49
  • [28] Epigenetic reprogramming in treatment-resistant breast cancer
    Brooke LaFlamme
    [J]. Nature Genetics, 2014, 46 (5) : 423 - 423
  • [29] Epigenetic Reprogramming of Germ Cells and Relevance to Testicular Cancer
    Kimmins, Sarah
    Lambrot, Romain
    [J]. JOURNAL OF ANDROLOGY, 2010, : 21 - 21
  • [30] Editorial: Epigenetic Reprogramming and Cancer Development Volume II
    Sanchez-Garcia, Isidro
    Vicente-Duenas, Carolina
    Brown, Geoffrey
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
12345